Since becoming only the second Alzheimer’s-modifying drug to gain American FDA approval in 2023, sales of lecanemab, known by its brand name Leqembi, have risen steadily, reaching $87-million USD...
Thursday March 27th 2025 • 4:30pm to 6pm
Leacock Building #232, 855 Sherbrooke West
Lori Leibold Ph.D.
Senior Director • Center for Hearing Research
Speaker Bio
Professors Guojun Chen, Mahsa Dadar and Phoebe Friesen – all members of the Faculty of Medicine and Health Sciences – win President’s Prize for Outstanding Emerging Researchers ...